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ABSTRACT
We introduce data assimilation as a computational method that uses machine learning to combine data with
human knowledge in the form of mechanistic models in order to forecast future states, to impute missing data
from the past by smoothing, and to infer measurable and unmeasurable quantities that represent clinically and
scientifically important phenotypes. We demonstrate the advantages it affords in the context of type 2 diabetes
by showing how data assimilation can be used to forecast future glucose values, to impute previously missing
glucose values, and to infer type 2 diabetes phenotypes. At the heart of data assimilation is the mechanistic
model, here an endocrine model. Such models can vary in complexity, contain testable hypotheses about im-
portant mechanics that govern the system (eg, nutrition’s effect on glucose), and, as such, constrain the model
space, allowing for accurate estimation using very little data.
Key words: data assimilation, Bayesian inverse methods, state space models, self-monitoring data, machine learning, data min-
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INTRODUCTION
Prediction is fundamental to medical practice, both to select treat-
ment and to gauge prognosis. Despite centuries of amassing biomed-
ical knowledge and decades of increasing reliance on computing and
information technologies, predictions in medicine remain imprecise
and generic. For example, knowledge of endocrine physiology and
detailed glucose measurements have not led to precise (ie, quantita-
tive patient-level) predictions in type 2 diabetes. We would like pre-
cise predictions regarding the impact of nutrition on glycemic
control, but instead nutritional therapy in diabetes relies on findings
generated by population-wide studies and consultation with clinical
experts.1 Our physiologic knowledge is sometimes quantitatively
encoded in mathematical models,2 but the models are approximate,
vary significantly by patient, and are not personalized unless
entrained with previous and incoming data. Techniques such as
deep learning3 promise to predict the future without mechanistic
knowledge, learning the structure directly from the data, but they
are limited in settings with sparse, irregular, inaccurate data, and
they do not bring much understanding about the patient or the dis-
ease beyond their predictions.
Data assimilation (DA),4–6 known also as state space models,
point processors,7–10 Kalman filters,11 and linear dynamical systems,
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is a regression method meant to solve inverse problems (estimating
model parameters),12,13 often in the context of solving a forward
problem (issuing a forecast) and was initially developed in contexts
of space travel by Kalman and Brownian motion by Thiele.14 Con-
ceptually, DA (Figure 1) takes a model believed to represent a sys-
tem being studied and synchronizes the model with data by
estimating states and parameters of the system. In this way, DA pro-
vides a bridge between physiology and empirical data, such that im-
perfect models and sparse data can be co-leveraged to overcome
each other’s failings. The physiology constrains the learning process,
minimizing the data required, while the data tailor the model to the
patient and synchronize it with the patient. Furthermore, DA can be
integrated with control algorithms,17 so that instead of predicting
the future under current conditions, it predicts what changes need to
be made today to reach a desired outcome in the future. At its es-
sence, DA is a family of regression methods that project data onto a
physiologically meaningful mechanistic model the way linear regres-
sion projects data onto simpler linear models and the way deep
learning projects data onto more flexible but data-hungry neural
networks. DA has advanced over the decades from its original for-
mulation as a linear, stochastic method to more recently developed
nonlinear approaches.
The purpose of this perspective is to introduce, or re-introduce,
biomedical informatics to the long-standing approach to
prediction—using mechanistic modeling to make data-driven
predictions—because we believe it has application well beyond its
current use in biomedical informatics. There are recent advances in
DA, such as the development of nonlinear filters that allow DA to
be used on problems biomedical informatics focuses on in particu-
lar, including prediction and furthering biological and medical sci-
ence using data collected over the process of giving care.
Forecasting, at its foundation, is about helping people make better
decisions, ie, decision support, and DA has the potential to be able
to make predictions with data collected over the course of current
clinical care, eg, with far less data than are needed for many other
techniques. But DA also requires integration with an informatics
pipeline to be made useful. The raw output of a DA is not useful be-
cause it is generally too complex in its raw from and must be trans-
lated to a user in a way users can understand and use in their
decision workflow. This makes the application of DA an interdisci-
plinary informatics problem. But biomedical informatics is not lim-
ited to clinical care alone because it lives at an interface between
basic science and clinical applications. When DA is used in the in-
verse problems,13,18 its smoothing context, DA addresses another
key goal of biomedical informatics, using clinical data to drive basic
science. The goal of smoothing is to fill in the past and to infer fea-
tures and physiology we cannot directly measure. In atmospheric
science, reanalysis data,19 or the DA output of the past that includes
the entire physics of the atmosphere well beyond what can be mea-
sured, is used to train new models, including non-mechanistic ma-
chine learning type models, to study the physical system. It is easy to
imagine inverse problems approaches to physiology following a sim-
ilar path in translational bioinformatics. Our goal is to inform infor-
matics that new machinery exists to apply DA to these informatics
applications.
Because of the intuitively fundamental nature of DA, there have
been many formulations of the same basic idea. For example, a tra-
ditional Bayesian machine is Dempster–Shafer,20–23 a belief function
for reasoning given uncertainty that is used to fuse empirical sources
of information. The continuous version of Dempster–Shafer can be
formulated as a linear Kalman filter,24 where the DA state space and
the Dempster–Shafer frame of discernment are equivalent. Thus, the
methods in this paper can be framed as a nonlinear, continuous be-
lief network.
DA has transformed fields such as space travel, weather forecast-
ing, flight, and manufacturing. It has seen some use in biomedicine
for decades, usually in data-rich settings and usually in its linear for-
mulation. Early examples of connecting mathematical physiologic
models to data include Hodgkin and Huxley,25 who proposed a
model of neurons, and Mackey and Glass,17 who proposed a model
of physiologic control systems. DA has been used in biomedicine in
several settings: algorithms in implantable defibrillators and pace-
makers to cope with irregular heartbeats,26–29 model construction
and fitting for prostate cancer treatment,30,31 the artificial pancreas
for type 1 diabetes,32–38 pharmacodynamics,39–42 female reproduc-
tive endocrinology,43 sleep modeling,44 ICU glucose forecast-
ing,38,45–47 many uses in epidemiology,48 viral modeling,49 and
inverse physiologic problems in general.13,18
The inavailability of data and previously limited methods for in-
tegrating data with nonlinear physiologic models may have re-
stricted the degree to which DA has permeated biomedicine. This
situation may be improving. For example, we have recently shown
Figure 1. Schematic diagram of how data assimilation synchronizes a model with data by estimating parameters and states. The model equation is drawn from
the ultradian glucose model.15,16
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that we can use sparse, inaccurate data collected in the course of
care paired with a simple glucose-insulin model to produce accurate
postprandial glucose and hemoglobin A1c predictions.15 This
worked despite the relatively complex physiology of type 2 diabetes.
This example demonstrates that recent and continuous development
of nonlinear methods together with the availability of clinical data,
self-monitoring data, etc., provide room for substantial advance-
ment and associated challenges.
The mechanistic model aspect of DA allows it to bear several
novel results. It can produce optimal predictions given the measured
data under the constraints of the physiological model, such as for
post-meal glucose. It can recommend actions needed to produce de-
sired outcomes, such as what meal must I eat to keep my peak glu-
cose below some threshold? The unmeasured but estimated model
parameters may represent useful patient phenotypes, such as de-
creased or changing kidney function and liver function, insulin se-
cretion rates, stress response, etc. The model can produce smoothed
versions of the sparse data, such as interpolating the glucose be-
tween measurements and then using that output to infer an aggre-
gate measurement such as hemoglobin A1c. And the DA can test a
mechanistic physiologic hypothesis by estimating how parameters
change when circumstances change, or by comparing models with
differing physiology.
To understand the power of DA methodologically, consider
what Al Roker, an NBC weatherman, was able to discuss on Octo-
ber 3, 2016, when reporting the path of Hurricane Matthew. In a
short two-minute video segment, Roker showed the size and path of
the hurricane, forecast seven days into the future, using three differ-
ent model-driven DAs. By doing this, the audience was shown not
only a believable, actionable weather forecast, but also how and
why the forecast was uncertain intuitively. One can imagine how
such technology could transform medicine.
We illustrate DA with real data from a type 2 diabetes patient in
Figure 2. Figure 2A has a two-day sample of sparse finger-prick glu-
cose measurements and meal data; Figure 2B adds the point-wise
DA glucose forecasts for the patient using an ultradian glucose
model.50 Figure 2C has the DA’s continuous glucose predictions and
continuous uncertainty estimates, which appear to be over fit.
Figure 2D, however, shows the underlying continuous glucose moni-
tor, whose data were withheld from the DA. The match is uncanny,
yet the oscillations in the glucose level could never have been learned
from the sparse finger-prick data alone. Only by using physiological
knowledge implicit in the ultradian model could those oscillations
have been predicted. Moreover, the second bump in glucose at 85.6
days, which appeared to have been missed by the DA (Figure 2B),
was actually just a several-minute miscalculation (Figure 2D).
Data assimilation inference
There are several ways to frame DA; here we use Bayesian infer-
ence.12 Bayesian inference can be summarized with Bayes formula:
p hjyð Þ / L hjyð ÞpðhÞ
where y are the data, h are the parameters, pðhjyÞ is the posterior dis-
tribution or the model predictions given data, and L is the likelihood
function. The goal of Bayesian inference and prediction is to charac-
terize the posterior distribution. It is determined by our prior knowl-
edge and the likelihood function. The likelihood contains our
understanding of mechanisms and determines how current data, ini-
tial conditions, and parameters are mapped to future states and
parameters. The predictive model determining the likelihood, eg, a
glucose-insulin model, generates forecasts, smooths data, and quan-
tifies uncertainty.
In the simplest situation, the predictive model determining the
likelihood is linear. The linear case formulated by Kalman in the
1960s11 has been applied often with great success, and is the
“optimal” linear filter. Nevertheless, many situations are not, and
cannot be made, linear. When the predictive model determining the
likelihood is nonlinear, meaning the current states are a complex
function of the past, estimating the likelihood is substantially more
difficult. A primary goal of machine learning and related fields is to
infer the nonlinear likelihood using data alone. While DA can be
cast within this framework, it can also incorporate mechanistic
knowledge of the likelihood function using mechanistic equations
that constrain, limit, and probabilistically determine the values the
states can take. Many methods for this computation exist, including
iterative methods, such as dual unscented Kalman filters51,52 and ex-
tended Kalman filters,53,54 and Markov chain Monte Carlo-based
methods,55–57 such as ensemble Kalman filters58,59 and particle fil-
ters.9 Here we use 2 methods, a dual unscented Kalman filter we
previously developed15 and a Metropolis–Hastings-within-Gibbs
Markov chain Monte Carlo method, explained in detail55 and dem-
onstrated in.60
If the system generating the data—an individual’s endocrine
system—changes in time, then the parameters must adapt in time
also. Continuous parameter estimation can be done online or off-
line. Online means the parameters are computed in real time as data
arrive. Offline means the parameters are computed on the whole
data set in retrospect. Filters such as the dual unscented Kalman fil-
ter can continuously adapt parameters in time because they are com-
putationally cheap, whereas computationally intensive techniques,
such as those based on Markov chain Monte Carlo, are usually used
offline. It is also possible to treat parameters as unknown functions
that evolve in time.55
Mechanistic models
At the core of DA lies a mechanistic (physiological) model that enco-
des our knowledge about a given system. The model depends on the
domain area and the goal. We use the ultradian endocrine model2,50
as an example for the rest of the paper; we summarize it here and
note the full description of the model can be found in.15,61,62 The
differential equations for the three state variables are:
dIp
dt
¼ f1ðGÞ  E Ip
Vp
 Ii
Vi
 
 Ip
tp
dIi
dt
¼ E Ip
Vp
 Ii
Vi
 
 Ii
ti
dG
dt
¼ f4ðh3Þ þ IGðtÞ  f2ðGÞ  f3ðIiÞG
where, eg, Ip is plasma insulin, Ii is remote (non-plasma) insulin, and
G is glucose. Our physiologic understanding is encoded in these
equations. For example, the first equation describes how plasma in-
sulin changes in time as a function of other state variables, parame-
ters, and parameterized physiologic processes. The time rate of
change of plasma insulin is dependent on the rate of insulin produc-
tion minus the rate of exchange between remote and plasma insulin
times the concentration of plasma insulin minus the remote insulin,
all minus the amount of plasma insulin divided by rate at which
plasma insulin degrades. The DA estimates parameters, eg, the ex-
change rate between remote and plasma insulin, E, and estimates,
forecasts and tracks the time evolution of the state variables, eg, Ii as
1394 Journal of the American Medical Informatics Association, 2018, Vol. 25, No. 10
D
ow
nloaded from
 https://academ
ic.oup.com
/jam
ia/article-abstract/25/10/1392/5128461 by C
alifornia Institute of Technology user on 22 O
ctober 2018
far into the future as is desired, being corrected whenever new data
are encountered. Every model represents a computable hypothesis of
how a physiologic system functions and how important variables
interact to represent the system.
Model error, identifiability, and uncertainty
quantification
Model error—the difference between the model and the physical
system—represents both parameter errors and the functional
difference between the model, fit perfectly, and the physiologic sys-
tem it is designed to represent. Identifiability18 is the theoretical
property of a model’s ability to have its parameters estimated given
ideal data. Models can have completely, partially, or un-identifiable
parameter sets. Uncertainty quantification63,64 is the identification,
quantification, and reduction of all error types.
Depending on the application, model error, identifiability, and
uncertainty quantification must be addressed to differing degrees.
When biological fidelity is required, estimated parameters should
have detailed uncertainty estimates and their identifiability proper-
Figure 2. (A) Finger-prick glucose measurements and meal carbohydrates serve as the training data (one segment shown) with a goal to predict glucose in the fu-
ture. (B) DA’s point-wise forecasts seem reasonable but not perfect, predicting one spike but missing another. (C) Underlying continuous DA forecast with uncer-
tainty quantification (which the point-wise forecasts are based on) appears to overfit the data with large glucose swings. (D) Continuous glucose monitoring,
which was hidden from the DA, reveals striking overlap between the continuous DA predictions and the actual glucose levels. Despite insufficient information in
the training set, the DA tracked glucose well based on the combination of its glucose metabolism constraints and the sparse measurements.
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ties must be explained. Figure 2C shows very coarse uncertainty
quantification at forecast points, which can be sharpened con-
siderably with more advanced techniques. Quantified model er-
ror is the primary focus when developing new models, averaging
models, or comparing several models as hypotheses.65–67 When
an accurate clinical forecast is important, uncertainty quantifi-
cation is essential for putting trustworthy bounds on forecast
reliability.
Forecasting the future
To forecast glucose in real time we use a dual unscented Kalman fil-
ter. In previous work we have used that filter to forecast glucose for
people with type 2 diabetes mellitus15 using only sparse, irregular
finger-prick data. In Figure 2, discussed in the introduction, we use
finger-prick glucose and carbohydrate data to estimate continuous
glucose using the dual unscented Kalman filter and compare this
forecast with the output of a continuous glucose monitor.
Figure 3. Continuous glucose monitor data, finger-prick glucose measurements, Markov chain Monte Carlo-based DA smoothing using finger-prick data, and
spline smoothing using only finger-prick data. The spline, with no physiologic constraints, can deviate wildly from the real glucose measurements, while the
physiologically constrained DA glucose inferences closely resemble the continuous glucose monitor data. The spline does not have enough data to infer the
physiology necessary to constrain its inferences. In contrast, the DA, leveraging physiologic knowledge, is able to infer glucose dynamics that are impossible to
infer according to the sampling theorem, because of the hardcoded physiologic knowledge with very little data.
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Completing the past
Sometimes it is important to impute missing data or parameters us-
ing sparse past measurements influenced by noisy external factors—
the essential task of smoothing. Figure 3 compares continuous glu-
cose measurements and continuous glucose estimates from both a
Metropolis-within-Gibbs DA using the ultradian model and a cubic
spline smoother.68,69 Both smoothing techniques use only finger-
prick data to estimate the most probable curve that generated the
finger-prick data from the set of all possible curves available to the
model class. The DA, constrained by physiology, matches the glu-
cose oscillations well. The spline smoother, free to select any curve
that minimizes the error, is unconstrained by physiology and selects
a curve that minimizes error but has non-physical off-data oscilla-
tions. Contrasting the DA with the spline estimates shows the conse-
quences of physiologic constraints: the root mean squared errors
between the continuous glucose data and the continuous DA and
spline glucose estimates were 16 mg/dl and 110 mg/dl, respectively.
The knowledge-based physiologic constraints decrease model flexi-
bility in a way that increases accuracy.
We use a spline here not because it is the best smoother, although
splines are very able smoothers designed to balance goodness of fit
against smoothness based on derivatives, but rather to demonstrate
the problem machine learning faces when not anchored to a me-
chanical model: choosing the most probable curve to represent the
data according to a cost function sans physiologic constraints with
sparse, irregular data may not accurately represent the underlying sys-
tem. While compressed sensing70,71offers some hope of coping with
inference using sparse data, the sampling theorem72,73 still poses a
fundamental limitation of machine learning with sparse data.
Comparing DA to many other regression methods is complex be-
cause DAs often involve iterative estimation of parameters that can
start close to or far from optimality. Moreover, DA carries a contin-
uous simulation of the system, while other methods generally do
not. But comparisons can still be informative. We compare DA in a
next-step prediction task with linear regression and a non-model-
based nonlinear regression, Gaussian process regression. These
methods iterate through the data set estimating model parameters
using the previous N preprandial glucose and carbohydrates to pre-
dict postprandial glucose measurements; they then use that model to
predict the (Nþ1)th postprandial glucose measurement.
The bottom plot in Figure 3 shows DA compared with linear re-
gression forecasts. The linear regression represents the mean glucose
well, but does not capture any oscillatory glycemic behavior, impli-
cating the subtleties of model evaluation. The mean squared error
for linear regression is approximately bounded by r/2, while for DA
it can be greater than 2r, because linear regression approximates
the mean response and DA approximates the oscillating trajectory.
Because of this, evaluation metrics can have different meanings for
different prediction tasks and methods. Table 1 shows forecast
errors for the next-step task for linear and Gaussian process regres-
sion for different training window lengths, N. While DA outper-
forms linear regression and Gaussian processes77 for this
participant, this is not always the case.15 Moreover, the table shows
both mean and root mean squared errors, forecast validation metrics
that emphasize different forecast features in their evaluation. The
MSE places a greater emphasis on outlier errors, while RMSE places
a greater emphasis on approximating the mean. Forecast verification
metrics heavily influence forecast machinery evaluation and must be
selected based on the goal of the forecasting task;74,75 it is common
and recommended in evaluation analyses to use several verification
metrics.
Phenotyping the present
DA can potentially be used for mechanism-based phenotyping, esti-
mating phenotypes composed of features that govern, determine,
and directly correspond to patient physiology. In Figure 4, we see
the posterior probability densities of the Markov Chain Monte
Carlo parameter estimates for the ultradian model for two peo-
ple, one with type 2 diabetes and one with normal endocrine
function. Both Markov chains converge to distinctly different pa-
rameter values, or phenotypes relative to the presence of diabe-
tes. The densities in Figure 4 reveal that parameters affecting
insulin secretion and insulin-dependent glucose utilization are
distinctly different for the diabetic and non-diabetic participant.
Uncertainty quantification for parameter estimates can be de-
rived from the parameter estimate densities; eg, the mean and
variance of the 2 phenotypes do not overlap. This example,
showing only 2 people, is meant only to demonstrate how to use
DA to construct higher fidelity phenotypes78 rooted in physio-
logic mechanics.
The foundational ideas of DA are not new—regression, Kal-
man filters, etc.—but DA has gone mostly unused in biomedical in-
formatics. There are several potential reasons for this, and some
reasons that this should change. DA, especially integrated with
mechanisms, is not really in the mainstream intellectual lineage of
informatics. Similarly, in its linear form—the Kalman filter or lin-
ear dynamical system—while extremely powerful, cf. its use for
the artificial pancreas or in pacemakers, is also relatively limited
and has data requirements that informatics researchers almost
never have. When DA is used in medicine, it is often used with the
goal of circumventing clinicians and patients with a closed-loop
formulation, an approach that is more akin to bioengineering than
bioinformatics; again cf. the artificial pancreas or pacemakers.
These applications, developed and applied in data-rich environ-
ments, did not easily translate to data-poor environment informat-
ics inhabits that include data collected in the course of maintaining
health.
Table 1. Mean squared error and root mean squared error of next
measured glucose for DA, linear regression, and Gaussian process
modeling vs. training set size. Comparing the MSE with the RMSE
highlights the impacts of selecting different forecast validation
metrics.74,75.The MSE places more weight on outlier or excursion
error, whereas the RMSE places more weight on errors associated
with estimating the mean, an interpretation that can be seen by
comparing the formulas of RMSE and MSE. The DA used here was
the unscented Kalman filter without optimizing or carefully select-
ing parameters estimated; it adjusted the model as new data arrive
so the concept of a training set for the DA is not equivalent to the
training set of the other two regressions. While the DA is the best
forecasting engine for this person, this is not always the case.15
Moreover, DA forecasting errors can be further reduced by at least
20% if the parameters estimated are more carefully chosen76
N¼ 5 N¼ 10 N¼ 15 N¼ 20 N¼ 25
Mean Squared Error
DA 340 340 340 340 340
Linear regression 555 425 380 385 380
Gaussian process 505 405 410 480 490
Root MSE
DA 18 18 18 18 18
Linear regression 24 21 19 20 19
Gaussian process 22 20 20 22 22
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Underuse of data assimilation
Similarly, the linear form of DA also lacks the capability to utilize
more realistic modeling, a severe limitation, as most physiologic sys-
tems and models are nonlinear. This lack of realism also reduced the
amount of knowledge incorporated into the system, simultaneously
decreasing the functional flexibility and the functional restrictions of
the models that often restricted their usefulness. The chief innova-
tion that circumvents these problems, the development of nonlinear
filtering techniques, was developed largely away from biomedicine,
and certainly away from informatics, within data-rich environments
such as robotics. The advent of nonlinear filtering opens the door to
methodological innovation, clinical decision innovation, and basic
scientific innovation using clinical data. This innovation does not
mean that all DA methodology problems are solved; they are not, but
DA is in a place now where it can be developed in the informatics con-
text with clinically collected data that were previously believed to be
inadequate, noisy, and generally not useful in the DA context. More-
over, to identify and then overcome DA innovations, the interdisci-
plinary pipeline from bench to machine to bedside is critical. And here
the informatics perspective is special—informatics methodological
innovations are driven by needs identified while integrating and as-
sembling computational machinery for use in clinical and basic sci-
ence contexts. It is this sociologic reason, this lack of siloed research
approaches, that necessitates informatics adoption of DA.
Figure 4.Markov chain Monte Carlo-based mechanistic model parameter estimates the Markov chains that minimized the mean square error for a normal person
and a person with type 2 diabetes mellitus. The plot shows the distributions of 3 parameters, C2, an exponential term affecting insulin-independent glucose utili-
zation, Rm, a linear constant affecting insulin secretion, and Um, a linear constant affecting insulin-dependent glucose utilization. The converged parameters take
distinctly different values for each individual, revealing the type 2 diabetes phenotype as mechanistically different with parameters that are difficult to measure.
While a full external validation of these phenotypic parameter estimates, the parameters are internally validated by minimizing the mean squared error. This plot
shows the potential for DA to produce higher-fidelity, mechanistic-physiology anchored phenotypes.
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Limiting factors and next steps
DA’s use of mechanistic models brings limitations as well as advan-
tages. As a regression, DA’s task is to select the most probable
curve from those restricted by what is mechanically possible
rather than from the set of linear functions or neural networks. If
the mechanistic model is too wrong—if the human knowledge or
insight is wrong—then the model error will prevent accurate ap-
proximation. Furthermore, because the model is created to repre-
sent physiology rather than the data scenario, it can have non-
identifiable parameters and fail to have a unique set of optimal
parameters. And finally, the initial state and parameters matter
for DA performance and affect the data requirements—if the
starting point of the states or parameters is very wrong, the
model will make a poor forecast. In contrast, more flexible meth-
ods such as deep learning can approximate nearly any distribu-
tion.79,80 This universal approximator flexibility comes at a cost
of substantially greater data requirements, an inability to cope
with nonstationary systems, and interpretation difficulties; deep
learning also shares some of DA’s identifiability challenges.
These approaches are not mutually exclusive and can comple-
ment each other.
DA can better serve biomedicine if there are advancements in
several areas. Methodological advancements include incorporating
clinically meaningful constraints and improving initial parameter
seeding, which give DA greater forecasting skill with particularly
small data sets. DA can benefit from integrating with machine learn-
ing to manage external factors with model errors, such as parameter
selection, forecast correction, and model averaging.15,66,67 Physio-
logical models require development, selection, and refinement, and
they may benefit from tailoring to the real-world clinical care data
that are available, and they must be created or adapted to meet prac-
tical intervention needs. And finally, we must advance our under-
standing of how to best integrate DA output into scientific, clinical,
and self-management workflows. For example, it is not enough to
produce a glucose and nutrition-based glucose forecast; the forecast
must be made in a way that enables behavioral adaptation. All of
these advancements are needed to unlock the potential of DA in a
biomedical context.
CONCLUSION
DA is an established way to combine mechanistic knowledge with
empirical data. It constrains the search space so that machine learn-
ing can proceed in the setting of limited data; eg, using 5 to 20 ran-
domly sampled data points to resolve continuous-time physiology.
This is important in medicine because sources of data, such as elec-
tronic health records, are often sparse. It allows us to generate pre-
dictions, recommendations, smoothed measurements, and otherwise
unmeasurable phenotypes. While most mechanistic models may be
imperfect, by anchoring them to empirical data, DA adjusts them
and keeps them tied to the actual state. In this way, relatively simple
models can be highly effective. The ultradian glucose model is very
simple but produces accurate forecasts15 when used within DA.
We present DA here both because it is relatively underused in
biomedicine and to encourage further research. While some forms of
DA may be mature, more research is needed for using DA in the con-
text of biomedicine in order to handle sparse, potentially biased
data and to deliver forecasts and recommendations within clinical
settings.
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